Sorrento Therapeutics (SRNE) – Analyst Ratings
-
Dawson James Downgrades Sorrento Therapeutics (SRNE) to Neutral
-
UPDATE: Cantor Fitzgerald Starts Sorrento Therapeutics (SRNE) at Overweight
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SRNE Stock Lookup